Article

SOLX receives clearance for glaucoma implant use in Canada

SOLX has received clearance from Health Canada for the use of its 24-karat gold implant (SOLX Gold Shunt) during glaucoma surgery.

Waltham MA

-SOLX has received clearance from Health Canada for the use of its 24-karat gold implant (SOLX Gold Shunt) during glaucoma surgery.

The shunt is biocompatible, 99.95% pure gold, and is designed to provide a pathway for the flow of aqueous humor from the anterior chamber of the eye to the suprachoroidal space. It preserves precious eye surface and the ability to perform future surgical interventions without a bleb, according to the company.

In a prospective, open-label study of the implant with 12 months of follow-up, IOP was reduced 45.6% from best medicated baseline in patients in whom maximum medical therapy and at least one prior surgical intervention had failed, according to the company.

The company’s family of shunt devices joins its laser for trabeculoplasty (SOLX 790) in products that have been cleared for sale in Canada.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.